Heartflow (NASDAQ:HTFL) Insider Campbell Rogers Sells 23,933 Shares of Company Stock

Key Points

• Heartflow insider Campbell Rogers sold 23,933 shares at an average price of $55.01, generating approximately $1.32 million. The sale, conducted under a pre-arranged Rule 10b5-1 plan, reduced Rogers’ ownership by 24.58% to 73,453 shares.
• Heartflow shares recently traded at $57.01, near the company’s 52-week high of $57.74, with the stock’s 50-day and 200-day moving averages at $49.38 and $33.51, respectively.
• The company reported quarterly revenue of $64.08 million, up 47.7% year over year, and adjusted its loss to $0.07 per share versus analysts’ expected loss of $0.22. Analysts collectively rate the stock “Moderate Buy,” with a consensus price target of $48.62.

Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) insider Campbell Rogers sold 23,933 shares of the business's stock in a transaction on Thursday, October 22nd. The shares were sold at an average price of $55.01, for a total value of $1,316,554.33. Following the completion of the transaction, the insider owned 73,453 shares of the company's stock, valued at $4,040,649.53. This trade represents a 24.58% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Campbell Rogers also recently made the following trade(s):

• On Friday, September 18th, Campbell Rogers sold 19,682 shares of Heartflow stock. The stock was sold at an average price of $50.15, for a total value of $987,052.30.
• On Monday, August 17th, Campbell Rogers sold 9,219 shares of Heartflow stock. The stock was sold at an average price of $41.23, for a total value of $380,099.37.

Heartflow Price Performance

Shares of NASDAQ:HTFL traded up $0.30 during midday trading on Monday, reaching $57.01. The company's stock had a trading volume of 1,058,656 shares, compared to its average volume of 1,655,511. The business has a 50 day moving average price of $49.38 and a 200 day moving average price of $33.51. Heartflow, Inc. has a 1 year low of $20.13 and a 1 year high of $57.74.

Heartflow (NASDAQ:HTFL - Get Free Report) last posted its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%. The company had revenue of $64.08 million during the quarter. The business's revenue for the quarter was up 47.7% on a year-over-year basis. Equities research analysts forecast that Heartflow, Inc. will post -0.75 EPS for the current year.

Analyst Upgrades and Downgrades

HTFL has been the subject of a number of research analyst reports. Wells Fargo & Company upped their price objective on Heartflow from $37.00 to $39.00 and gave the stock an "overweight" rating in a report on Friday, August 14th. JPMorgan Chase & Co. lifted their target price on Heartflow from $35.00 to $45.00 and gave the company an "overweight" rating in a report on Friday, August 14th. Weiss Ratings raised Heartflow from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Friday, August 7th. Morgan Stanley upped their price target on Heartflow from $35.00 to $40.00 and gave the stock an "equal weight" rating in a research note on Friday, August 14th. Finally, Robert W. Baird set a $45.00 price objective on Heartflow in a report on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Heartflow presently has an average rating of "Moderate Buy" and a consensus price target of $48.62.

Institutional Trading of Heartflow

A number of institutional investors have recently added to or reduced their stakes in HTFL. Sterling Capital Management LLC grew its position in shares of Heartflow by 797.9% in the 3rd quarter. Sterling Capital Management LLC now owns 2,532 shares of the company's stock worth $126,000 after acquiring an additional 2,250 shares in the last quarter. Crescent Grove Advisors LLC acquired a new position in Heartflow in the third quarter worth $249,000. IFP Advisors Inc increased its stake in Heartflow by 844.7% during the third quarter. IFP Advisors Inc now owns 803 shares of the company's stock valued at $40,000 after purchasing an additional 718 shares during the last quarter. Vontobel Holding Ltd. bought a new stake in Heartflow during the third quarter valued at $1,020,000. Finally, Avior Wealth Management LLC raised its holdings in shares of Heartflow by 16.1% during the third quarter. Avior Wealth Management LLC now owns 14,553 shares of the company's stock worth $724,000 after purchasing an additional 2,023 shares during the period.

About Heartflow

Heartflow, Inc is a medical technology company that develops artificial intelligence-based tools to help physicians diagnose and manage coronary artery disease. Its platform uses data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient's coronary arteries and provide noninvasive assessments of blood flow and disease.

The company's products include Heartflow Analysis, which provides fractional flow reserve computed tomography (FFR-CT) evaluations to help identify potentially significant blockages, as well as tools for assessing coronary plaque and planning treatment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.